Analyst Price Targets — ABSI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 25, 2026 10:46 am | — | Morgan Stanley | $10.00 | $10.08 | TheFly | Absci price target raised to $10 from $4.10 at Morgan Stanley |
| June 25, 2026 10:01 am | — | H.C. Wainwright | $16.00 | $10.08 | TheFly | Absci price target raised to $16 from $8 at H.C. Wainwright |
| June 15, 2026 10:40 am | — | Guggenheim | $15.00 | $6.80 | TheFly | Absci price target raised to $15 from $10 at Guggenheim |
| June 4, 2026 10:30 am | — | Leerink Partners | $12.00 | $5.94 | TheFly | Absci initiated with an Outperform at Leerink |
| May 28, 2026 10:39 am | — | BTIG | $9.00 | $5.16 | TheFly | Absci initiated with a Buy at BTIG |
| May 14, 2026 12:01 pm | — | Morgan Stanley | $4.10 | $5.62 | TheFly | Absci price target lowered to $4.10 from $4.20 at Morgan Stanley |
| January 8, 2026 11:14 am | — | Morgan Stanley | $4.32 | $4.02 | TheFly | Absci downgraded to Equal Weight from Overweight at Morgan Stanley |
| December 17, 2025 5:38 pm | — | H.C. Wainwright | $8.00 | $3.44 | TheFly | Absci price target raised to $8 from $7 at H.C. Wainwright |
| March 21, 2024 1:40 pm | Daniel Arias | Stifel Nicolaus | $6.00 | $5.28 | StreetInsider | Absci Corp. (ABSI) PT Raised to $6 at Stifel |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ABSI

VANCOUVER, Wash. and NEW YORK, Sept.

On August 14, 2026, Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) filed its first-ever 13F, pulling back the curtain on a $1.31 billion equity portfolio concentrated in just six positions.

RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing proprietary clinical pipelines.

Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript

Absci NASDAQ: ABSI outlined progress in its clinical program for ABS-201, a prolactin receptor-targeting antibody being studied for pattern hair loss and planned for development in endometriosis, while reporting a larger cash balance following a June equity offering and strategic investment from Eli Lilly.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ABSI.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
